Month: March 2019
-
Infographic – 5G Phone Service to Far Surpass 4G
A chart comparing 5G service specifications compared to the latest 4G/LTE specs, from the Android Authority web site, this weekend’s infographic.
-
Genetic Risk Analysis Shows Ethnic Bias
Techniques analyzing data from across the genome that reveal risks of diseases, better predict disorders in the main ethnicity of the population studied than other ethnic groups.
-
Federal Agency Holds A.I.-Health Outcomes Challenge
The U.S. agency directing Medicare and Medicaid is sponsoring a challenge competition to spur development of artificial intelligence to predict health care outcomes.
-
Genome Editing Biotech Raises $126M in IPO
A biotechnology company developing treatments for disease and enhanced agricultural products with genome editing is raising $126 million in its initial public offering, or IPO, of common stock.
-
Brain Stimulator Device Cleared for Depression, Insomnia
A device sending weak electric impulses into the brain from headphones is authorized by the Food and Drug Administration to treat depression, anxiety, and insomnia.
-
Respiratory Vaccine Maker Raises $3.4M in Seed Funds
A company developing vaccines that protect against respiratory diseases in vulnerable populations is raising new seed funds to advance its lead product into clinical trials.
-
Start-Up Creating Off-the-Shelf Stem Cell Therapies
A new company is licensing technology from the lab of its co-founder at Harvard University to develop stem cell therapies for any recipients, without causing immune reactions.
-
Ancient DNA Studied for Mental Health Clues
A lab studying DNA from past civilizations and the genomics technology company Illumina are investigating remains of ancient peoples for insights into today’s neurological disorders.
-
App Created for New, Pregnant Moms in Opioid Recovery
A smartphone app is being developed to help pregnant women and new mothers with an opioid addiction, by a medical professor and health care technology company.
-
NSF Funding Natural Agri-Chemical Technology
A start-up company spun-off from Cornell University is receiving a small business grant to develop in crop plants a natural protection against pathogens.